CD8A and neoplasm: Both autologous and allogeneic tumor cell vaccines share one similar mechanism of facilitating immune responses that they can increase the production of IL‐2 and facilitate Th1 immunity, leading to the augmentation of downstream CD8+ and macrophages' responses [43, 66].